Related Experiment Video
Updated: Jun 15, 2026
07:16
Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
Published on: April 25, 2025
The National Cancer Institute's Cancer Disparities Research Partnership Program: a unique funding model 20 years
C Norman Coleman1, Rosemary Wong1, Daniel G Petereit2
1Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Journal of the National Cancer Institute
|September 14, 2023
Summary
The Cancer Disparities Research Partnership Program (CDRP) aimed to increase underserved populations
Area of Science:
- Health Services Research
- Cancer Disparities Research
- Radiation Oncology Clinical Research
Background:
- Cancer burden and treatment access are unequal in the U.S., particularly affecting underserved populations diagnosed with advanced cancers.
- Radiation oncology services are crucial for these populations, necessitating research initiatives to improve trial participation.
- The National Cancer Institute's Radiation Research Program established the Cancer Disparities Research Partnership Program (CDRP) in 2001 to address these gaps.
Purpose of the Study:
- To evaluate the long-term impact of the Cancer Disparities Research Partnership Program (CDRP) on participating institutions, communities, and investigators.
- To provide a 20-year retrospective analysis of CDRP's experiences and observations.
- To inform current and future equity, diversity, and inclusion (EDI) programs in cancer research.
Main Methods:
- A survey was administered to the six principal investigators (PIs) of CDRP awards.
- Five out of six PIs responded to the 10-question survey, which used a 5-point Likert scale.
- Patient data collection was not feasible due to the time elapsed since program completion.
Main Results:
- The survey captured retrospective insights from PIs regarding CDRP's influence on their institutions, communities, and career trajectories.
- The findings offer valuable perspectives on the practical implementation and outcomes of a pioneering disparities research funding model.
- The study highlights the lasting effects of CDRP, contributing to the understanding of research capacity building in underserved areas.
Conclusions:
- The experiences and observations from CDRP principal investigators offer critical lessons for developing and implementing effective EDI programs in cancer research.
- The retrospective analysis underscores the importance of targeted funding models in promoting research equity and inclusion.
- CDRP's legacy provides a foundation for future initiatives aimed at reducing cancer disparities through research.
More Related Videos
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...